TREATMENT OF ARTERIAL HYPOTENSION

DOI: https://doi.org/10.29296/25877305-2023-05-04
Issue: 
5
Year: 
2023

Professor K. Amlaev, MD; Associate Professor I. Znamenskaya, Candidate
of Medical Sciences; Associate Professor Kh. Dakhkilgova, Candidate of Medical Sciences
Stavropol State Medical University, Ministry of Health of Russia

Treatment of arterial hypotension is a complex problem that requires correction of the hemodynamic parameters of the patient and, if possible, an impact on the cause of a decrease in blood pressure. It is necessary to pay attention to the correction of factors aggravating the course of hypotension. It is also important to use non-drug methods of correction of low blood pressure, such as wearing compression underwear, increasing fluid and salt intake, the use of physical maneuvers and exercises. Pharmacological therapy of hypotension includes the use of a number of drugs with different mechanisms of action, such as midodrine, fludcortisone, droxidopa, norepinephrine membrane transporter inhibitors. Special attention is paid to the treatment of orthostatic hypotension, postprandial hypotension.

Keywords: 
cardiology
arterial hypotension
orthostatic hypotension
antihypotensive therapy.



References: 
  1. Meng L. Heterogeneous impact of hypotension on organ perfusion and outcomes: a narrative review. Br J Anaesth. 2021; 127 (6): 845–61. DOI: 10.1016/j.bja.2021.06.048
  2. Mascha E.J., Yang D., Weiss S. et al. Intraoperative Mean Arterial Pressure Variability and 30-day Mortality in Patients Having Noncardiac Surgery. Anesthesiology. 2015; 123 (1): 79–91. DOI: 10.1097/ALN.0000000000000686
  3. Hsieh J.K., Dalton J.E., Yang D. et al. The Association Between Mild Intraoperative Hypotension and Stroke in General Surgery Patients. Anesth Analg. 2016; 123 (4): 933–9. DOI: 10.1213/ANE.0000000000001526
  4. Hirsch J., DePalma G., Tsai T.T. et al. Impact of intraoperative hypotension and blood pressure fluctuations on early postoperative delirium after non-cardiac surgery. Br J Anaesth. 2015; 115 (3): 418–26. DOI: 10.1093/bja/aeu458
  5. Babazade R., Yilmaz H.O., Zimmerman N.M. et al. Association Between Intraoperative Low Blood Pressure and Development of Surgical Site Infection After Colorectal Surgery: A Retrospective Cohort Study. Ann Surg. 2016; 264 (6): 1058–64. DOI: 10.1097/SLA.0000000000001607
  6. Momodu I.I., Okafor C.N. Orthostatic Syncope. In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2022.
  7. Magkas N., Tsioufis C., Thomopoulos C. et al. Orthostatic hypertension: From pathophysiology to clinical applications and therapeutic considerations. J Clin Hypertens (Greenwich). 2019; 21 (3): 426–33. DOI: 10.1111/jch.13491
  8. Fumagalli U., Melis A., Balazova J. et al. Intra-operative hypotensive episodes may be associated with post-operative esophageal anastomotic leak. Updates Surg. 2016; 68 (2): 185–90. DOI: 10.1007/s13304-016-0369-9
  9. Magny E., Donadio C., Maronnat F. et al. Hypotensions in the elderly: Clinical and therapeutic features. Presse Med. 2019; 48 (2): 134–42. DOI: 10.1016/j.lpm.2018.11.008
  10. Bocti C., Pépin F., Tétreault M. et al. Orthostatic hypotension associated with executive dysfunction in mild cognitive impairment. J Neurol Sci. 2017; 382: 79–83. DOI: 10.1016/j.jns.2017.09.028
  11. Palma J.A., Kaufmann H. Management of Orthostatic Hypotension. Continuum (Minneap Minn). 2020; 26 (1): 154–77. DOI: 10.1212/CON.0000000000000816
  12. Newton J.L., Frith J. The efficacy of nonpharmacologic intervention for orthostatic hypotension associated with aging. Neurology. 2018; 91 (7): e652–e656. DOI: 10.1212/WNL.0000000000005994
  13. Fanciulli A., Goebel G., Metzler B. et al. Elastic Abdominal Binders Attenuate Orthostatic Hypotension in Parkinson's Disease. Mov Disord Clin Pract. 2015; 3 (2): 156–60. DOI: 10.1002/mdc3.12270
  14. Okamoto L.E., Diedrich A., Baudenbacher F.J. et al. Efficacy of Servo-Controlled Splanchnic Venous Compression in the Treatment of Orthostatic Hypotension: A Randomized Comparison With Midodrine. Hypertension. 2016; 68 (2): 418–26. DOI: 10.1161/HYPERTENSIONAHA.116.07199
  15. Fanciulli A., Jordan J., Biaggioni I. et al. Consensus statement on the definition of neurogenic supine hypertension in cardiovascular autonomic failure by the American Autonomic Society (AAS) and the European Federation of Autonomic Societies (EFAS): Endorsed by the European Academy of Neurology (EAN) and the European Society of Hypertension (ESH). Clin Auton Res. 2018; 28 (4): 355–62. DOI: 10.1007/s10286-018-0529-8
  16. Di Stefano C., Maule S. Treatment of supine hypertension in autonomic failure: a case series. Clin Auton Res. 2018; 28 (2): 245–6. DOI: 10.1007/s10286-017-0479-6
  17. Gibbons C.H., Schmidt P., Biaggioni I. et al. The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension. J Neurol. 2017; 264 (8): 1567–82. DOI: 10.1007/s00415-016-8375-x
  18. Grijalva C.G., Biaggioni I., Griffin M.R. et al. Fludrocortisone Is Associated With a Higher Risk of All-Cause Hospitalizations Compared With Midodrine in Patients With Orthostatic Hypotension. J Am Heart Assoc. 2017; 6 (10): e006848. DOI: 10.1161/JAHA.117.006848
  19. Lamotte G., Holmes C., Sullivan P. et al. Substantial renal conversion of L-threo-3,4-dihydroxyphenylserine (droxidopa) to norepinephrine in patients with neurogenic orthostatic hypotension. Clin Auton Res. 2019; 29 (1): 113–7. DOI: 10.1007/s10286-018-0564-5
  20. Hauser R.A., Biaggioni I., Hewitt L.A. et al. Integrated Analysis of Droxidopa for the Treatment of Neurogenic Orthostatic Hypotension in Patients with Parkinson Disease. Mov Disord Clin Pract. 2018; 5 (6): 627–34. DOI: 10.1002/mdc3.12695
  21. Palma J.A., Norcliffe-Kaufmann L., Martinez J. et al. Supine plasma NE predicts the pressor response to droxidopa in neurogenic orthostatic hypotension. Neurology. 2018; 91 (16): e1539–e1544. DOI:10.1212/WNL.0000000000006369
  22. Biaggioni I., Arthur Hewitt L., Rowse G.J. et al. Integrated analysis of droxidopa trials for neurogenic orthostatic hypotension. BMC Neurol. 2017; 17 (1): 90. DOI: 10.1186/s12883-017-0867-5
  23. Kaufmann H. Droxidopa for symptomatic neurogenic orthostatic hypotension: what can we learn? Clin Auton Res. 2017; 27 (Suppl 1): 1–3. DOI: 10.1007/s10286-017-0426-6
  24. Shibao C.A., Palma J.A., Celedonio J.E. et al. Predictors of the Pressor Response to the Norepinephrine Transporter Inhibitor, Atomoxetine, in Neurogenic Orthostatic Hypotension. Hypertension. 2021; 78 (2): 525–31. DOI: 10.1161/HYPERTENSIONAHA.119.14483
  25. Okamoto L.E., Shibao C.A., Gamboa A. et al. Synergistic Pressor Effect of Atomoxetine and Pyridostigmine in Patients With Neurogenic Orthostatic Hypotension. Hypertension. 2019; 73 (1): 235–41. DOI: 10.1161/HYPERTENSIONAHA.118.11790
  26. Pavelić A., Krbot Skorić M., Crnošija L. et al. Postprandial hypotension in neurological disorders: systematic review and meta-analysis. Clin Auton Res. 2017; 27 (4): 263–71. DOI: 10.1007/s10286-017-0440-8
  27. Abbas R., Tanguy A., Bonnet-Zamponi D. et al. New Simplified Screening Method for Postprandial Hypotension in Older People. J Frailty Aging. 2018; 7 (1): 28–33. DOI: 10.14283/jfa.2018.2
  28. Borg M.J., Xie C., Rayner C.K. et al. Potential for Gut Peptide-Based Therapy in Postprandial Hypotension. Nutrients. 2021; 13 (8): 2826. DOI: 10.3390/nu13082826
  29. Fedorowski A., Ricci F., Hamrefors V. et al. Orthostatic Hypotension: Management of a Complex, But Common, Medical Problem. Circ Arrhythm Electrophysiol. 2022; 15 (3): e010573. DOI: 10.1161/CIRCEP.121.010573
  30. Kaufmann H., Palma J.A. Neurogenic orthostatic hypotension: the very basics. Clin Auton Res. 2017; 27 (Suppl 1): 39–43. DOI: 10.1007/s10286-017-0437-3
  31. Dasgupta I., Thomas G.N., Clarke J. et al. Associations between Hemodialysis Facility Practices to Manage Fluid Volume and Intradialytic Hypotension and Patient Outcomes. Clin J Am Soc Nephrol. 2019; 14 (3): 385–93. DOI: 10.2215/CJN.08240718
  32. Strutt J., Flood A., Kharbanda A.B. Shock Index as a Predictor of Morbidity and Mortality in Pediatric Trauma Patients. Pediatr Emerg Care. 2019; 35 (2): 132–7. DOI: 10.1097/PEC.0000000000001733